Researcher profile

Zhao Peng

Zhao Peng contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
1topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2021arXiv

Development of a GPU-accelerated Monte Carlo dose calculation module for nuclear medicine, ARCHER-NM: Demonstration for a PET/CT imaging procedure

This paper describes the development and validation of a Monte Carlo (MC) dose computing module dedicated to organ dose calculations of patients undergoing nuclear medicine (NM) internal radiation exposures involving 18F-FDG PET/CT examination. This new module extends the more-than-10-years-long ARCHER project that developed a GPU-accelerated MC dose engine by adding dedicated NM source-definition features. To validate the code, we compared dose distributions from the 0.511-MeV point photon source calculated for a water phantom as well as a patient PET/CT phantom against a well-tested MC code, GATE. The water-phantom results show excellent agreement, suggesting that the radiation physics module in the new NM code is adequate. To demonstrate the clinical utility and advantage of ARCHER-NM, one set of PET/CT data for an adult male NM patient is calculated using the new code. Radiosensitive organs in the CT dataset are segmented using a CNN-based tool called DeepViewer. The PET image intensity maps are converted to radioactivity distributions to allow for MC radiation transport dose calculations at the voxel level. The dose rate maps and corresponding statistical uncertainties were calculated for the duration of PET image acquisition. The dose rate results of the 18F-FDG PET imaging patient show that ARCHER-NM's results agree very well with those of the GATE within 0.58% to 4.11%. Most impressively, ARCHER-NM obtains such results in less than 0.5 minutes while it takes GATE as much as 376 minutes. This is the first study presenting GPU-accelerated patient-specific MC internal radiation dose rate calculations for clinically realistic 18F-FDG PET/CT imaging cases involving auto-segmentation of whole-body PET/CT images. This study suggests that modern computing tools -- ARCHER-NM and DeepViewer -- are accurate and fast enough for routine internal dosimetry in NM clinics.

preprint2019arXiv

A Method of Rapid Quantification of Patient-Specific Organ Dose for CT Using Coupled Deep-Learning based Multi-Organ Segmentation and GPU-accelerated Monte Carlo Dose Computing

Purpose: This paper describes a new method to apply deep-learning algorithms for automatic segmentation of radiosensitive organs from 3D tomographic CT images before computing organ doses using a GPU-based Monte Carlo code. Methods: A deep convolutional neural network (CNN) for organ segmentation is trained to automatically delineate radiosensitive organs from CT. With a GPU-based Monte Carlo dose engine (ARCHER) to derive CT dose of a phantom made from a subject's CT scan, we are then able to compute the patient-specific CT dose for each of the segmented organs. The developed tool is validated by using Relative Dose Error (RDE) against the organ doses calculated by ARCHER with manual segmentation performed by radiologists. The dose computation results are also compared against organ doses from population-average phantoms to demonstrate the improvement achieved by using the developed tool. In this study, two datasets were used: The Lung CT Segmentation Challenge 2017 (LCTSC) dataset, which contains 60 thoracic CT scan patients each with 5 segmented organs, and the Pancreas-CT (PCT) dataset, which contains 43 abdominal CT scan patients each with 8 segmented organs. Five-fold cross-validation of the new method is performed on both datasets. Results: Comparing with the traditional organ dose evaluation method that based on population-average phantom, our proposed method achieved the smaller RDE range on all organs with -4.3%~1.5% vs -31.5%~33.9% (lung), -7.0%~2.3% vs -15.2%~125.1% (heart), -18.8%~40.2% vs -10.3%~124.1% (esophagus) in the LCTSC dataset and -5.6%~1.6% vs -20.3%~57.4% (spleen), -4.5%~4.6% vs -19.5%~61.0% (pancreas), -2.3%~4.4% vs -37.8%~75.8% (left kidney), -14.9%~5.4% vs -39.9% ~14.6% (gall bladder), -0.9%~1.6% vs -30.1%~72.5% (liver), and -23.0%~11.1% vs -52.5%~-1.3% (stomach) in the PCT dataset.